Biotech · Private company
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Track this companyFree. Adds Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ZX008 (Fenfluramine Hydrochloride)Phase 3 · Dravet SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ZX008 0.2 or 0.8 mg/kg/dayPhase 3 · Lennox Gastaut SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- CannabidiolPhase 1 · Dravet SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ZX008 0.2 to 0.8 mg/kg/dayPhase 1 · Dravet SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).PHASE3 · COMPLETED · started May 31, 2019ClinicalTrials.gov NCT03790137 · fetched Nov 12, 2026
- A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut SyndromePHASE3 · COMPLETED · started Apr 22, 2019ClinicalTrials.gov NCT03936777 · fetched Nov 12, 2026
- A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking CannabidiolPHASE1 · COMPLETED · started Jan 19, 2018ClinicalTrials.gov NCT03467113 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromePHASE3 · COMPLETED · started Nov 27, 2017ClinicalTrials.gov NCT03355209 · fetched Nov 12, 2026
- A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet SyndromePHASE3 · TERMINATED · started Jul 12, 2017ClinicalTrials.gov NCT03299842 · fetched Nov 12, 2026
- A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet SyndromePHASE3 · COMPLETED · started Jan 27, 2017ClinicalTrials.gov NCT02926898 · fetched Nov 12, 2026
- An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet SyndromePHASE3 · COMPLETED · started Jun 8, 2016ClinicalTrials.gov NCT02823145 · fetched Nov 12, 2026
- A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromePHASE3 · COMPLETED · started Jan 15, 2016ClinicalTrials.gov NCT02682927 · fetched Nov 12, 2026